OrbusNeich's Genous R Stent as Alternative to Drug-Eluting Stents

Armen Hareyan's picture

Genous R Stent


OrbusNeich announced that post-marketing data from patient subsets of a global registry support the use of the company's Genous Bio-engineered R stent as an alternative to drug-eluting stents.

Presented today by Robbert de Winter, M.D., Ph.D., at the European Society of Cardiology (ESC) Congress 2007 in Vienna, Austria, the data from OrbusNeich's e-HEALING registry show:


Share this content.

If you liked this article and think it may help your friends, consider sharing or tweeting it to your followers.